Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)
China
· Delayed Price · Currency is CNY 58.32
-0.24 (-0.41%)
Apr 30, 2026, 11:30 AM CST
SHA:688621 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 372.45 | 462.17 | 565.56 | 690.93 | 608.93 | 490.25 | Upgrade
|
| Short-Term Investments | - | - | 20 | - | - | - | Upgrade
|
| Trading Asset Securities | 47 | 75 | 30 | 30 | 13.11 | 157.6 | Upgrade
|
| Cash & Short-Term Investments | 419.45 | 537.17 | 615.56 | 720.93 | 622.04 | 647.85 | Upgrade
|
| Cash Growth | -37.45% | -12.74% | -14.62% | 15.90% | -3.98% | 492.70% | Upgrade
|
| Accounts Receivable | 1,034 | 935.3 | 774.96 | 555.83 | 362.73 | 239.2 | Upgrade
|
| Other Receivables | 7.49 | 6.65 | 10.16 | 11.21 | 16.17 | 12 | Upgrade
|
| Receivables | 1,041 | 941.95 | 785.12 | 567.04 | 378.9 | 251.21 | Upgrade
|
| Inventory | 14.67 | 14.03 | 15.05 | 14.41 | 12.54 | 7.84 | Upgrade
|
| Prepaid Expenses | - | - | - | - | - | 1.9 | Upgrade
|
| Other Current Assets | 245.37 | 247.47 | 98.76 | 54.76 | 26.48 | 32.99 | Upgrade
|
| Total Current Assets | 1,721 | 1,741 | 1,514 | 1,357 | 1,040 | 941.79 | Upgrade
|
| Property, Plant & Equipment | 167.69 | 177.91 | 211.61 | 220.26 | 197.02 | 161.05 | Upgrade
|
| Long-Term Investments | 199.51 | 159.41 | 115.69 | 100.75 | 94.75 | 40 | Upgrade
|
| Goodwill | 20.51 | 20.51 | 26.06 | 26.06 | 26.06 | 26.06 | Upgrade
|
| Other Intangible Assets | 4.05 | 4.73 | 5.41 | 5.39 | 4.2 | 3.32 | Upgrade
|
| Long-Term Deferred Tax Assets | 111.47 | 102.27 | 64.04 | 38.93 | 16.69 | 5.03 | Upgrade
|
| Long-Term Deferred Charges | 27.61 | 30.64 | 48.28 | 64.19 | 76.25 | 33.41 | Upgrade
|
| Other Long-Term Assets | 48.55 | 48.71 | 1.73 | 50.31 | 8.78 | 31.99 | Upgrade
|
| Total Assets | 2,300 | 2,285 | 1,987 | 1,863 | 1,464 | 1,243 | Upgrade
|
| Accounts Payable | 60.92 | 52.74 | 7.31 | 7.83 | 22.13 | 12.52 | Upgrade
|
| Accrued Expenses | 22.18 | 30.74 | 77.24 | 88.72 | 37.29 | 27.33 | Upgrade
|
| Short-Term Debt | 508.93 | 499.13 | 309.39 | 383.93 | 201.17 | 138.01 | Upgrade
|
| Current Portion of Long-Term Debt | 34.62 | 36.83 | 19.3 | - | - | - | Upgrade
|
| Current Portion of Leases | - | - | 24.78 | 22.1 | 22.54 | 18.98 | Upgrade
|
| Current Income Taxes Payable | 40.65 | 39.47 | 6.6 | 24.92 | 16.93 | 11.42 | Upgrade
|
| Current Unearned Revenue | 284.87 | 299.15 | 321.43 | 220.83 | 205.85 | 199.85 | Upgrade
|
| Other Current Liabilities | 10.29 | 10.58 | 12.51 | 12.88 | 12.27 | 9.72 | Upgrade
|
| Total Current Liabilities | 962.47 | 968.65 | 778.56 | 761.21 | 518.19 | 417.83 | Upgrade
|
| Long-Term Debt | 38.4 | 48 | 67.2 | - | - | - | Upgrade
|
| Long-Term Leases | 26.7 | 29.75 | 35.12 | 40.62 | 33.84 | 49.72 | Upgrade
|
| Long-Term Unearned Revenue | 3.57 | 3.57 | 2.52 | 3.59 | 2.83 | 5.46 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.02 | 0.05 | 1.25 | 0.35 | 0.24 | - | Upgrade
|
| Other Long-Term Liabilities | 1.28 | 1.28 | - | - | - | - | Upgrade
|
| Total Liabilities | 1,032 | 1,051 | 884.65 | 805.76 | 555.1 | 473.01 | Upgrade
|
| Common Stock | 112 | 112 | 112 | 112 | 80 | 80 | Upgrade
|
| Additional Paid-In Capital | 422.36 | 406.54 | 375.86 | 474.17 | 499.85 | 499.85 | Upgrade
|
| Retained Earnings | 819.46 | 798.83 | 612.78 | 453.85 | 317.09 | 182.1 | Upgrade
|
| Treasury Stock | -100 | -100 | - | - | - | - | Upgrade
|
| Total Common Equity | 1,254 | 1,217 | 1,101 | 1,040 | 896.93 | 761.95 | Upgrade
|
| Minority Interest | 13.92 | 16.12 | 2.01 | 17.25 | 11.67 | 7.69 | Upgrade
|
| Shareholders' Equity | 1,268 | 1,233 | 1,103 | 1,057 | 908.6 | 769.64 | Upgrade
|
| Total Liabilities & Equity | 2,300 | 2,285 | 1,987 | 1,863 | 1,464 | 1,243 | Upgrade
|
| Total Debt | 608.65 | 613.71 | 455.79 | 446.65 | 257.55 | 206.71 | Upgrade
|
| Net Cash (Debt) | -189.2 | -76.55 | 159.77 | 274.28 | 364.48 | 441.14 | Upgrade
|
| Net Cash Growth | - | - | -41.75% | -24.75% | -17.38% | 414.12% | Upgrade
|
| Net Cash Per Share | -1.71 | -0.70 | 1.42 | 2.45 | 3.26 | 4.50 | Upgrade
|
| Filing Date Shares Outstanding | 114.62 | 109.66 | 112 | 112 | 112 | 112 | Upgrade
|
| Total Common Shares Outstanding | 114.62 | 109.66 | 112 | 112 | 112 | 112 | Upgrade
|
| Working Capital | 758.31 | 771.97 | 735.93 | 595.93 | 521.77 | 523.96 | Upgrade
|
| Book Value Per Share | 10.94 | 11.10 | 9.83 | 9.29 | 8.01 | 6.80 | Upgrade
|
| Tangible Book Value | 1,229 | 1,192 | 1,069 | 1,009 | 866.68 | 732.57 | Upgrade
|
| Tangible Book Value Per Share | 10.72 | 10.87 | 9.55 | 9.01 | 7.74 | 6.54 | Upgrade
|
| Machinery | - | - | 256.34 | 232.62 | 195.9 | 124.14 | Upgrade
|
| Construction In Progress | - | - | - | - | - | 3.4 | Upgrade
|
| Order Backlog | - | - | 3,273 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.